Journal Article

Detection of the Variant Frequency in Human Erythrocytes using Glycophorin a Locus Mutation Assay

H.X. Gui and W.Y. Cheng

in Radiation Protection Dosimetry

Volume 77, issue 1-2, pages 37-41
Published in print May 1998 | ISSN: 0144-8420
Published online May 1998 | e-ISSN: 1742-3406 | DOI: http://dx.doi.org/10.1093/oxfordjournals.rpd.a032292
Detection of the Variant Frequency in Human Erythrocytes using Glycophorin a Locus Mutation Assay

More Like This

Show all results sharing this subject:

  • Nuclear Chemistry, Photochemistry, and Radiation

GO

Show Summary Details

Preview

Glycophorin A (GPA) is the major glycoprotein on human erythrocyte membranes, and bears M and N blood group determinants. Genotoxic exposure causes erythroid precursor cells to mutate at the glycophorin. A locus, producing phenotypes of rare variant erythrocytes that lack the expression of one form of the protein. The BR6 assay is now the most widely used method to determine the variant frequency (Vf) by immunolabelling and flow cytometry. In this study, two kinds of labelling were used. Second antibody labelling, namely BRIC157-sheep anti-mouse IgG-FITC binding, increased the sensitivity, while the specificity and the precision decreased. NO/NN Vf of 10 normal samples conform with previous reports, 7.96 ± 3.05/2.24 ± 1.05 (x10-6) and 10.12 ± 3.2/3.95 ± 1.02 (x10-6) of direct and indirect dyeing respectively. Some factors affect the dyes emitting fluorescence, and the optimal temperature of immunolabelling is under 20(C.

Journal Article.  0 words. 

Subjects: Nuclear Chemistry, Photochemistry, and Radiation

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.